Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Opiant Pharmaceuticals, Inc. (the "Company") previously announced the appointment of Craig A. Collard to Chairman of the Company's Board of Directors (the "Board"), effective January 1, 2021. On January 14, 2021, the Board approved an annual retainer of $50,000 for the Board's Chairman position.

In addition, on January 14, 2021, the Board appointed Dr. Gabrielle Silver to the Compensation Committee of the Board.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses